Bainbridge Island, WA, United States of America

Antonio Campos-Nero

This inventor holds 1 USPTO granted patent. Top assignee: Corixa Corporation. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonio Campos-Nero. Retrieved from https://idiyas.com/inventor/antonio-campos-nero

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Antonio Campos-Nero: Innovator in Fusion Proteins

Introduction

Antonio Campos-Nero is a notable inventor based in Bainbridge Island, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His work focuses on innovative solutions for the diagnosis, treatment, and prevention of tuberculosis infection.

Latest Patents

Antonio Campos-Nero holds 1 patent related to fusion proteins that contain multiple antigens. This patent encompasses bi-fusion proteins with two antigens, tri-fusion proteins with three antigens, tetra-fusion proteins with four antigens, and penta-fusion proteins with five antigens. These advancements are crucial for enhancing the effectiveness of tuberculosis diagnostics and therapies.

Career Highlights

Antonio is associated with Corixa Corporation, where he has been instrumental in advancing research in the field of immunology. His expertise in fusion proteins has positioned him as a key player in the development of innovative medical solutions.

Collaborations

Antonio has collaborated with esteemed colleagues such as Steven G. Reed and Yasir A. Skeiky. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the pursuit of groundbreaking innovations.

Conclusion

Antonio Campos-Nero's contributions to the field of fusion proteins exemplify his commitment to advancing medical science. His innovative work continues to pave the way for new approaches in the fight against tuberculosis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…